Addressing the financial gap in IBS care

Financial barriers remain one of the most persistent challenges in delivering guideline-aligned IBS care. Even when therapies are evidence-based and recommended in clinical guidelines, many patients find them difficult to access due to out-of-pocket costs.

Recognizing this, Nerva introduced its Patient Assistance Program (PAP) to make brain-gut therapy accessible for every patient, while maintaining a streamlined process for clinicians.

Through this program, coverage now extends up to full access at no cost for eligible patients.

Automatic coverage for referred patients

All patients referred through Nerva’s  HIPAA-compliant clinician referral form automatically receive a 25% referral adjustment, reducing the annual subscription cost to $186.75 AUD or $149.25 USD.

This discount is applied universally to every form-based referral, helping remove a key cost barrier for patients seeking evidence-based brain-gut therapy.

How patients apply for the Patient Assistance Program

The simple process ensures equitable access to brain-gut therapy without adding any administrative work for clinicians.
‍
How patients apply:

  1. Clinicians refer as per usual via Nerva’s secure online form.
  2. After a referral is received, Nerva contacts patients via email to begin onboarding and share information about available assistance options.

Supporting equity and implementation in clinical practice

By simplifying financial access and minimizing clinician workload, the Patient Assistance Program supports more consistent implementation of guideline-supported brain-gut therapies across patient populations.

In practice, this helps clinicians align with new quality indicators from leading gastroenterology societies like the AGA and pediatric guidelines from NASPGHAN and ESPGHAN that emphasize access to behavioral interventions as a central component of IBS management.

Making evidence-based care affordable

Ultimately, programs like PAP demonstrate that evidence-based care and affordability can coexist – improving treatment continuity and helping patients experience the long-term benefits of brain-gut therapy without financial strain.

Talk to us

If you have any questions, schedule a call with our Clinical Specialists who can share all of Nerva's cost-saving options and walk you through the program in more detail.

Contents